Literature DB >> 17626090

Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis.

Yael Friedman-Levi1, Haim Ovadia, Romana Hoftberger, Ofira Einstein, Oded Abramsky, Herbert Budka, Ruth Gabizon.   

Abstract

During the years or decades of prion disease incubation, at-risk individuals are certain to encounter diverse pathological insults, such as viral and bacterial infections, autoimmune diseases, or inflammatory processes. Whether prion disease incubation time and clinical signs or otherwise the pathology of intercurrent diseases can be affected by the coinfection process is unknown. To investigate this possibility, mice infected with the scrapie agent at both high and low titers were subsequently induced for experimental autoimmune encephalomyelitis, an immune system-mediated model of central nervous system (CNS) inflammation. We show here that co-induced mice died from a progressive neurological disease long before control mice succumbed to classical scrapie. To investigate the mechanism of the co-induced syndrome, we evaluated biochemical and pathological markers of both diseases. Brain and spleen PrP(Sc) levels in the dying co-induced mice were comparable to those observed in asymptomatic scrapie-infected animals, suggesting that co-induced disease is not an accelerated form of scrapie. In contrast, inflammatory markers, such as demyelination, immune cell infiltrates, and gliosis, were markedly increased in co-induced mouse spinal cords. Activated astrocytes were especially elevated in the medulla oblongata. Furthermore, PrP(sc) depositions were found in demyelinated white matter areas in co-induced mouse spinal cords, suggesting the presence of activated infected immune cells that infiltrate into the CNS to facilitate the process of prion neuroinvasion. We hypothesize that inflammatory processes affecting the CNS may have severe clinical implications in subjects incubating prion diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626090      PMCID: PMC2045403          DOI: 10.1128/JVI.00780-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  Prions and the immune system: a journey through gut, spleen, and nerves.

Authors:  Adriano Aguzzi
Journal:  Adv Immunol       Date:  2003       Impact factor: 3.543

2.  Chronic-relapsing experimental allergic encephalomyelitis in Lewis rats: correlation between clinical state and antimyelin basic protein reactivity in draining lymph node cells.

Authors:  D Chabannes; J F Borel
Journal:  Transplant Proc       Date:  1990-12       Impact factor: 1.066

3.  Cellular isoform of the scrapie agent protein participates in lymphocyte activation.

Authors:  N R Cashman; R Loertscher; J Nalbantoglu; I Shaw; R J Kascsak; D C Bolton; P E Bendheim
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

4.  Scrapie-infected spleens: analysis of infectivity, scrapie-associated fibrils, and protease-resistant proteins.

Authors:  R Rubenstein; P A Merz; R J Kascsak; C L Scalici; M C Papini; R I Carp; R H Kimberlin
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

5.  Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo.

Authors:  Ursula Unterberger; Romana Höftberger; Ellen Gelpi; Helga Flicker; Herbert Budka; Till Voigtländer
Journal:  J Neuropathol Exp Neurol       Date:  2006-04       Impact factor: 3.685

6.  Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia.

Authors:  Peter Bannerman; Ashleigh Hahn; Athena Soulika; Vittorio Gallo; David Pleasure
Journal:  Glia       Date:  2007-01-01       Impact factor: 7.452

7.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

8.  Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system.

Authors:  Y Matsumoto; K Ohmori; M Fujiwara
Journal:  J Neuroimmunol       Date:  1992-03       Impact factor: 3.478

Review 9.  The role of the cellular prion protein in the immune system.

Authors:  J D Isaacs; G S Jackson; D M Altmann
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

10.  Kuru in the 21st century--an acquired human prion disease with very long incubation periods.

Authors:  John Collinge; Jerome Whitfield; Edward McKintosh; John Beck; Simon Mead; Dafydd J Thomas; Michael P Alpers
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

View more
  10 in total

1.  Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever.

Authors:  S A Appel; J Chapman; E Kahana; H Rosenmann; I Prohovnik; E Pras; H Reznik-Wolf; O S Cohen
Journal:  Eur J Neurol       Date:  2010-01-20       Impact factor: 6.089

2.  Detection of PrPSc in lung and mammary gland is favored by the presence of Visna/maedi virus lesions in naturally coinfected sheep.

Authors:  Eider Salazar; Eva Monleón; Rosa Bolea; Cristina Acín; Marta Pérez; Neila Alvarez; Iratxe Leginagoikoa; Ramón Juste; Esmeralda Minguijón; Ramsés Reina; Idoia Glaria; Eduardo Berriatua; Damián de Andrés; Juan José Badiola; Beatriz Amorena; Lluís Luján
Journal:  Vet Res       Date:  2010-04-29       Impact factor: 3.683

3.  Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection.

Authors:  Yael Friedman-Levi; Romana Hoftberger; Herbert Budka; Tehila Mayer-Sonnenfeld; Oded Abramsky; Haim Ovadia; Ruth Gabizon
Journal:  J Neuroinflammation       Date:  2012-03-21       Impact factor: 8.322

4.  Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection.

Authors:  Rocio Castro-Seoane; Holger Hummerich; Trevor Sweeting; M Howard Tattum; Jacqueline M Linehan; Mar Fernandez de Marco; Sebastian Brandner; John Collinge; Peter-Christian Klöhn
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

5.  Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice.

Authors:  Pascal Leblanc; Kim Hasenkrug; Anne Ward; Lara Myers; Ronald J Messer; Sandrine Alais; Andrew Timmes; Suzette A Priola; Sue Priola
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

6.  Aggregation of MBP in chronic demyelination.

Authors:  Kati Frid; Ofira Einstein; Yael Friedman-Levi; Orli Binyamin; Tamir Ben-Hur; Ruth Gabizon
Journal:  Ann Clin Transl Neurol       Date:  2015-06-06       Impact factor: 4.511

Review 7.  Molecular pathology of human prion diseases.

Authors:  Gabor G Kovacs; Herbert Budka
Journal:  Int J Mol Sci       Date:  2009-03-09       Impact factor: 5.923

8.  Repetitive immunization enhances the susceptibility of mice to peripherally administered prions.

Authors:  Juliane Bremer; Mathias Heikenwalder; Johannes Haybaeck; Cinzia Tiberi; Nike Julia Krautler; Michael O Kurrer; Adriano Aguzzi
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

9.  Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.

Authors:  Orli Binyamin; Liraz Larush; Kati Frid; Guy Keller; Yael Friedman-Levi; Haim Ovadia; Oded Abramsky; Shlomo Magdassi; Ruth Gabizon
Journal:  Int J Nanomedicine       Date:  2015-11-20

Review 10.  The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis.

Authors:  Neil A Mabbott; Barry M Bradford; Reiss Pal; Rachel Young; David S Donaldson
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.